Vijaya Diagnostic Centre Limited has announced a postal ballot seeking shareholder approval for the appointment of two Independent Directors to strengthen its board governance. The company filed the notice with stock exchanges on April 09, 2026, outlining the proposed appointments and voting procedures.

Proposed Director Appointments

The postal ballot covers two special resolutions for Independent Director appointments:

Both directors were initially appointed as Additional Directors on February 13, 2026, subject to shareholder approval through this postal ballot process.

Voting Timeline and Process

The company has established a comprehensive timeline for the postal ballot process:

The company has engaged KFin Technologies Limited to provide remote e-voting facilities to shareholders. The postal ballot notice is being sent electronically to members whose email addresses are registered with the company or depository participants.

Director Profiles and Expertise

Mr. Ravi Shankararamiah brings over four decades of legal experience as a Senior Advocate with expertise in taxation, corporate and commercial laws, securities and capital markets, mergers and acquisitions, and dispute resolution. He holds degrees from Bangalore University and the University of Southern California, graduating magna cum laude.

Dr. Sasikala Paruchuri Kola contributes over three decades of healthcare experience as a senior Consultant Gynaecologist and Obstetrician. She holds an MD and DGO from Osmania Medical College and has held key leadership positions in professional bodies including the Federation of Obstetric and Gynaecological Societies of India.

Regulatory Compliance

The appointments comply with provisions of the Companies Act, 2013, and SEBI Listing Regulations. Both directors have submitted required statutory disclosures, including:

• Consent to act as directors in Form DIR-2
• Declarations confirming independence criteria
• Confirmations of non-disqualification under Section 164(2)
• Registration in the Independent Directors' Databank

The Board of Directors has recommended both special resolutions for shareholder approval, emphasizing the directors' relevant expertise and potential contributions to the company's governance and strategic decision-making processes.

Vijaya Diagnostic Centre Limited has announced a key leadership change with the resignation of its Company Secretary & Compliance Officer. The diagnostic services company informed stock exchanges about this corporate development through a regulatory filing.

Leadership Transition Details

Mr. Hansraj Singh has resigned from his position as Company Secretary & Compliance Officer of the company, with his last working day scheduled for March 16, 2026. The resignation was submitted due to personal reasons, as disclosed in the company's official communication to the stock exchanges.

Resignation Communication

In his resignation email addressed to the management, Singh explained his decision to step down from his role. He cited his intention to pursue new professional opportunities that align with his long-term career growth and development goals. Singh expressed gratitude for the opportunities, support, and trust extended to him by the management and team during his tenure with the company.

The outgoing Company Secretary emphasized his commitment to ensuring a smooth and seamless transition process. He assured the management that he would dedicate his efforts to effectively hand over his responsibilities before his departure.

Company's Response

Vijaya Diagnostic Centre has acknowledged Singh's resignation and placed on record its deep appreciation for the services rendered by him. The company recognized his contributions during his time as Company Secretary & Compliance Officer. The management expressed gratitude for his dedicated service and the valuable relationships he built within the organization.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was submitted to both the National Stock Exchange of India Limited and BSE Limited, ensuring compliance with regulatory requirements for such corporate announcements.

The resignation represents a planned leadership transition, with Singh expressing his best wishes for the company's continued success and growth in the years ahead.